This article is sponsored by CMW Media, the premier public and media relations agency proudly serving the cannabis industry worldwide.
Medical Marijuana, Inc., the first publicly traded cannabis company in the United States, will provide the government of the State of Mexico with medical-grade CBD hemp oil products from its subsidiary HempMeds Mexico®, which will be used in the treatment of patients suffering from a variety of conditions including refractory epilepsy and Lennox Gastaut-Syndrome.
The deal marks the first time a government in Mexico has purchased CBD products for its citizens, and follows a series of steps in Mexico’s courts and legislature that have made CBD products more accessible to patients. These include the approval of CBD products from HempMeds Mexico by the Mexican health ministry COFEPRIS.
Mexico is just the latest nation in Latin America to make it easier for patients to integrate CBD products into their healthcare regimens. Since 2015, similar steps have been taken by the governments of Brazil and Paraguay.
The State of Mexico’s Governor Eruviel Avila Villegas distributed HempMeds Mexico’s flagship product Real Scientific Hemp Oil-X™ (RSHO-X™), a CBD hemp oil containing zero THC, to patients during the opening of a new clinic in the Mexico City suburb of Ecatepec. Avila was joined at the event by Mexican cannabis activist Raul Elizalde and César Nomar Gómez Monge, Health Minister of the State of Mexico.
The State of Mexico’s Health Minister, César Nomar Gómez Monge, speaks on the potential treatment value of CBD for epilepsy patients. (Moises Ramirez)
“We want to congratulate the State of Mexico’s government for this historic purchase of our CBD products to help relieve the suffering of its citizens,” said Medical Marijuana, Inc. president and CEO Dr. Stuart Titus.
“We are a company of firsts, and this is another first. We are excited to achieve the historic milestone of having the Mexican government purchase our CBD products to benefit its citizens. The plethora of benefits of medical cannabis in treating several types of indications is undeniable, and we are encouraged to see not only healthcare professionals, [but] now also governments, become increasingly interested in how CBD hemp oil can help heal.”
Epilepsy is among the many indications that can benefit from medical marijuana products. A new study led by Dr. Saul Garza Morales, a pediatric researcher and neurologist in Mexico, helps expand on that body of work.
Recently, Dr. Garza Morales shared the positive results of a recent study he conducted on the effects of Medical Marijuana, Inc.’s RSHO-X™ product in treating children with severe epilepsy. Dr. Garza and his collaborators found that 86% of the 38 patients included in the study saw the frequency of their motor seizures cut in half. Five subjects were even totally seizure-free for four full months, a result that is usually only achieved following major surgeries.
“With the advent of RSHO-X therapy, doctors have a new approach—using natural CBD in its natural, botanical form,” said Dr. Garza. “This has shown to control seizure episodes in epilepsy children to a significant degree, meaning invasive surgeries are now a resort of last measure.”
Thank you for visiting MDMMCC.com, the premier Medical Marijuana Certification Center in Maryland. Our Mission at the Maryland Medical Marijuana Certification Clinics (MDMMCC) is to provide the certification necessary for qualified patients to obtain Medical Marijuana in compliance with the Maryland Medical Marijuana Laws in the State of Maryland. MDMMCC will have offices open throughout Maryland.